LSX Congress USA (LSX USA) is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most:

• Capital to support the next stage of growth

• Pharma partnerships with strategic value

• Focused visibility, partnering and momentum

LSX Congress USA (or LSX USA) is a leading event focusing on the US and life sciences sector, bringing together biotech leaders, pharma executives and active investors.

Designed for companies raising capital, pursuing strategic partnerships and preparing for their next phase of growth, the event connects founders, CEOs and senior executives with the people and opportunities that can help move their business forward. Through high-quality content, targeted networking, 1:1 partnering and investor engagement, LSX Congress USA supports biotech companies in building relationships, securing funding and advancing strategic goals.

Whether you are an early-stage biotech or a more established company looking to connect with pharma, LSX Congress USA is a gateway to the partnerships and conversations that drive growth.